{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T10:32:43Z","timestamp":1766313163164,"version":"3.48.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymgmr.2025.101252","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T01:16:52Z","timestamp":1758071812000},"page":"101252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Improving sapropterin administration efficacy in PKU: Clinical practice case studies"],"prefix":"10.1016","volume":"45","author":[{"given":"Martina","family":"Tosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Ashmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Vijay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Verduci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2025.101252_bb0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/nu14030576","article-title":"Dietetic management of adults with phenylketonuria (PKU) in the UK: a care consensus document","volume":"14","author":"Robertson","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgmr.2025.101252_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"van Wegberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107684","article-title":"Metabolic control and clinical outcome in adolescents with phenylketonuria","volume":"140","author":"De Giorgi","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-020-01391-y","article-title":"PKU dietary handbook to accompany PKU guidelines","volume":"15","author":"MacDonald","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(02)09334-0","article-title":"How practical are recommendations for dietary control in phenylketonuria?","volume":"360","author":"Walter","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2025.101252_bb0030","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3390\/nu16132064","article-title":"Blood phenylalanine levels in patients with phenylketonuria from Europe between 2012 and 2018: is it a changing landscape?","volume":"16","author":"Pinto","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgmr.2025.101252_bb0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3476(99)70138-1","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"135","author":"Kure","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0040","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","article-title":"The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with Oral Sapropterin Dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study","volume":"30","author":"Burton","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0045","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of Sapropterin Dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2025.101252_bb0050","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2008.11.040","article-title":"Efficacy of Sapropterin Dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study","volume":"154","author":"Trefz","year":"2009","journal-title":"J. Pediatr."},{"author":"Kuvan","key":"10.1016\/j.ymgmr.2025.101252_bb0060"},{"key":"10.1016\/j.ymgmr.2025.101252_bb0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2019.04.004","article-title":"International best practice for the evaluation of responsiveness to Sapropterin Dihydrochloride in patients with phenylketonuria","volume":"127","author":"Muntau","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0075","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/nu13031040","article-title":"Protein substitute requirements of patients with phenylketonuria on BH4 treatment: a systematic review and meta-analysis","volume":"13","author":"Ilgaz","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgmr.2025.101252_bb0080","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3390\/nu15163603","article-title":"Impact on diet quality and burden of care in sapropterin dihydrochloride use in children with phenylketonuria: a 6 month follow-up report","volume":"15","author":"Gama","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgmr.2025.101252_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymgme.2019.07.018","article-title":"Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria","volume":"128","author":"Zori","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401353","article-title":"Current advances and material innovations in the search for novel treatments of phenylketonuria","volume":"13","author":"Delbreil","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10545-008-0964-0","article-title":"Tetrahydrobiopterin in intestinal lumen: its absorption and secretion in the small intestine and the elimination in the large intestine","volume":"32","author":"Sawabe","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13023-017-0600-x","article-title":"Efficacy, safety and population pharmacokinetics of Sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial","volume":"12","author":"Muntau","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0105","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1096-7192(02)00171-3","article-title":"High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002","volume":"77","author":"Bernegger","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymgme.2003.09.014","article-title":"Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration","volume":"81","author":"Fiege","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/mgme.2001.3168","article-title":"Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype","volume":"73","author":"Lindner","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymgme.2003.11.008","article-title":"Long-term follow-up of a patient with mild tetrahydrobiopterin-responsive phenylketonuria","volume":"81","author":"Cerone","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgmr.2025.101252_bb0125","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.ymgme.2005.07.024","article-title":"Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin","volume":"86","author":"B\u00e9langer-Quintana","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgmr.2025.101252_bb0130","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ymgme.2005.05.014","article-title":"Clinical and nutritional evaluation of Phenylketonuric patients on tetrahydrobiopterin monotherapy","volume":"86","author":"Lambruschini","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13023-015-0227-8","article-title":"Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience","volume":"10","author":"Scala","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0140","doi-asserted-by":"crossref","first-page":"e1881","DOI":"10.1542\/peds.2012-3291","article-title":"Long-term follow-up and outcome of phenylketonuria patients on Sapropterin: a retrospective study","volume":"131","author":"Keil","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2025.101252_bb0145","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1515\/jpem-2016-0461","article-title":"Improved metabolic control in tetrahydrobiopterin (BH4), responsive phenylketonuria with Sapropterin administered in two divided doses vs. a single daily dose","volume":"30","author":"K\u00f6r","year":"2017","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clinthera.2010.02.012","article-title":"Relative bioavailability of Sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults","volume":"32","author":"Musson","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2012.04.004","article-title":"Recommendations for the use of sapropterin in phenylketonuria","volume":"106","author":"Cunningham","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0007114511000298","article-title":"Adjusting diet with sapropterin in phenylketonuria: what factors should be considered?","volume":"106","author":"MacDonald","year":"2011","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ymgmr.2025.101252_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymgme.2014.10.013","article-title":"Adherence to tetrahydrobiopterin therapy in patients with phenylketonuria","volume":"114","author":"Rohr","year":"2015","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T10:30:56Z","timestamp":1766313056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426925000679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"alternative-id":["S2214426925000679"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101252","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving sapropterin administration efficacy in PKU: Clinical practice case studies","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101252"}}